These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29846449)

  • 1. Immune response and biochemistry of calves immunized with rMSP1a ( Anaplasma marginale) using carbon nanotubes as carrier molecules.
    Silvestre BT; Silveira JAGD; Facury-Filho EJ; Carvalho AÚ; Versiani AF; Estevam LGTM; Araújo MSS; Martins-Filho OA; Negrão-Corrêa DA; Ribeiro MFB
    Rev Bras Parasitol Vet; 2018; 27(2):191-202. PubMed ID: 29846449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of humoral and cellular immune response of BALB/c mice immunized with a recombinant fragment of MSP1a from Anaplasma marginale using carbon nanotubes as a carrier molecule.
    Silvestre BT; Rabelo ÉM; Versiani AF; da Fonseca FG; Silveira JA; Bueno LL; Fujiwara RT; Ribeiro MF
    Vaccine; 2014 Apr; 32(19):2160-6. PubMed ID: 24606864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of B-cell epitopes in the N-terminal repeated peptides of Anaplasma marginale major surface protein 1a and characterization of the humoral immune response of cattle immunized with recombinant and whole organism antigens.
    Garcia-Garcia JC; de la Fuente J; Kocan KM; Blouin EF; Halbur T; Onet VC; Saliki JT
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):137-51. PubMed ID: 15010223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the effectiveness of an inactivated vaccine from Anaplasma marginale derived from tick cell culture.
    Lasmar PV; Carvalho AÚ; Facury Filho EJ; Bastos CV; Ribeiro MF
    Rev Bras Parasitol Vet; 2012; 21(2):112-7. PubMed ID: 22832750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale.
    Zhao L; Mahony D; Cavallaro AS; Zhang B; Zhang J; Deringer JR; Zhao CX; Brown WC; Yu C; Mitter N; Middelberg AP
    PLoS One; 2016; 11(4):e0154295. PubMed ID: 27115492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope-based vaccines with the Anaplasma marginale MSP1a functional motif induce a balanced humoral and cellular immune response in mice.
    Santos PS; Sena AA; Nascimento R; Araújo TG; Mendes MM; Martins JR; Mineo TW; Mineo JR; Goulart LR
    PLoS One; 2013; 8(4):e60311. PubMed ID: 23579784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-protection between geographically distinct Anaplasma marginale isolates appears to be constrained by limited antibody responses.
    Kenneil R; Shkap V; Leibovich B; Zweygarth E; Pfister K; Ribeiro MF; Passos LM
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():97-104. PubMed ID: 24589108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of bovines using a DNA vaccine (pcDNA3.1/MSP1b) prepared from the Jaboticabal strain of Anaplasma marginale.
    de Andrade GM; Machado RZ; Vidotto MC; Vidotto O
    Ann N Y Acad Sci; 2004 Oct; 1026():257-66. PubMed ID: 15604503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of cattle with Anaplasma marginale derived from tick cell culture.
    Kocan KM; Halbur T; Blouin EF; Onet V; de la Fuente J; Garcia-Garcia JC; Saliki JT
    Vet Parasitol; 2001 Dec; 102(1-2):151-61. PubMed ID: 11705661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A partially purified outer membrane protein VirB9-1 for low-cost nanovaccines against Anaplasma marginale.
    Zhao L; Cavallaro AS; Wibowo D; Zhang B; Zhang J; Mitter N; Yu C; Zhao CX; Middelberg AP
    Vaccine; 2017 Jan; 35(1):77-83. PubMed ID: 27890399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a subcutaneous ear implant to deliver an anaplasmosis vaccine to dairy steers.
    Curtis AK; Reif KE; Kleinhenz MD; Martin MS; Skinner B; Kelly SM; Jones DE; Schaut RG; Reppert EJ; Montgomery SR; Narasimhan B; Anantatat T; Jaberi-Douraki M; Coetzee JF
    J Anim Sci; 2020 Jun; 98(6):. PubMed ID: 31889177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine.
    Lopez JE; Palmer GH; Brayton KA; Dark MJ; Leach SE; Brown WC
    Infect Immun; 2007 May; 75(5):2333-42. PubMed ID: 17339347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response of BALB/c mouse immunized with recombinant MSPs proteins of Anaplasma marginale binding to immunostimulant complex (ISCOM).
    Kawasaki PM; Kano FS; Tamekuni K; Garcia JL; Marana ER; Vidotto O; Vidotto MC
    Res Vet Sci; 2007 Dec; 83(3):347-54. PubMed ID: 17395222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three methods of immunization against bovine anaplasmosis: an examination of postvaccinal effects.
    Corrier DE; Vizcaino O; Carson CA; Ristic M; Kuttler KL; Treviño GS; Lee AJ
    Am J Vet Res; 1980 Jul; 41(7):1062-5. PubMed ID: 7436099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge.
    Sarli M; Novoa MB; Mazzucco MN; Signorini ML; Echaide IE; de Echaide ST; Primo ME
    PLoS One; 2020; 15(2):e0229301. PubMed ID: 32084216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of IgG2-specific antigens in Mexican Anaplasma marginale strains.
    Barigye R; García-Ortiz MA; Rojas Ramírez EE; Rodríguez SD
    Ann N Y Acad Sci; 2004 Oct; 1026():84-94. PubMed ID: 15604474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced immune response of DNA vaccine encoding an association MSP1a, MSP1b, and MSP5 antigens of Anaplasma marginale.
    Kano FS; Tamekuni K; Coelho AL; Garcia JL; Vidotto O; Itano EN; Vidotto MC
    Vaccine; 2008 Jun; 26(27-28):3522-7. PubMed ID: 18502005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplasma marginale Yucatan (Mexico) Strain. Assessment of low virulence and potential use as a live vaccine.
    Rodríguez Camarillo SD; García Ortiz MA; Rojas Ramírez EE; Cantó Alarcón GJ; Preciado de la Torre JF; Rosario Cruz R; Ramos Aragón JA; Aboytes Torres R
    Ann N Y Acad Sci; 2008 Dec; 1149():98-102. PubMed ID: 19120183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG and IgG2 antibodies from cattle naturally infected with Anaplasma marginale recognize the recombinant vaccine candidate antigens VirB9, VirB10, and elongation factor-Tu.
    Araújo FR; Costa CM; Ramos CA; Farias TA; Souza II; Melo ES; Elisei C; Rosinha GM; Soares CO; Fragoso SP; Fonseca AH
    Mem Inst Oswaldo Cruz; 2008 Mar; 103(2):186-90. PubMed ID: 18425271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant Protein.
    Ducken DR; Brown WC; Alperin DC; Brayton KA; Reif KE; Turse JE; Palmer GH; Noh SM
    PLoS One; 2015; 10(6):e0129309. PubMed ID: 26079491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.